NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

Yes I do, in fact, I seem to remember Linda Powers saying that was 1 reason they decided to have the Glioblastoma Phase 3 trial first, because if they could prove significant safety and efficacy in treating Glioblastoma, then it should be easier to treat solid tumor cancers in other organs, because you do not have to deal with the blood-brain barrier.

However, because of the immunosuppressive nature of solid tumor cancers micro-environments in general, and regardless of which organ(s) the tumors are located, combination treatments may always need to be used for maximum efficacy.

I hope that anyone else who remembers this statement by Linda Powers, will also chime in.